These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5270161)

  • 21. [Blood coagulation activity in patients with chronic hepatitis and cirrhosis of the liver, treated with glucocorticoid hormones].
    Zlatkina AR; Levantovskaia OM; Kravtsova EF
    Ter Arkh; 1972 Apr; 44(4):98-102. PubMed ID: 5051568
    [No Abstract]   [Full Text] [Related]  

  • 22. The present status of corticosteroid therapy in liver diseases.
    Tygstrup N
    Scand J Gastroenterol; 1969; 4(5):393-5. PubMed ID: 4900647
    [No Abstract]   [Full Text] [Related]  

  • 23. [Glucocorticoid hormones in the complex therapy of chronic hepatitis and liver cirrhosis in children].
    Menlkova TN; Deputatova-Kunitsyna LD; Lyskova TF
    Pediatriia; 1970 Sep; 49(9):72-3. PubMed ID: 5482155
    [No Abstract]   [Full Text] [Related]  

  • 24. [Indications, method and effectiveness of immunosuppressive treatment in chronic active hepatopathies. I. Changes in the general dynamics of the disease. II. Slowing-down of the chronicization process].
    Nicolaescu T; Stoiculescu P; Bittman E; Bordeianu A; Gheorghe N; Pintilescu V; Metz L
    Med Interna (Bucur); 1974 Apr; 26(4):453-64. PubMed ID: 4839352
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anabolic steroids and liver diseases].
    Wewalka F
    Wien Med Wochenschr; 1967 Mar; 117(12):293-9. PubMed ID: 4871957
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of chronic hepatitis.
    Mistilis SP; Lam KC
    Prog Liver Dis; 1972; 4():419-32. PubMed ID: 4569006
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution.
    Baggenstoss AH; Soloway RD; Summerskill WH; Elveback LR; Schoenfield LJ
    Hum Pathol; 1972 Jun; 3(2):183-98. PubMed ID: 5028616
    [No Abstract]   [Full Text] [Related]  

  • 28. [Thiomesterone and liver function].
    Pickert H
    Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of chronic hepatitis and liver cirrhosis].
    Kommerell B
    Med Welt; 1974 Nov; 25(46):1904-10. PubMed ID: 4456135
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-inflammatory treatment of chronic active liver disease.
    Tygstrup N
    Prog Liver Dis; 1970; 3():319-35. PubMed ID: 4908704
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long-term therapy of liver diseases].
    Renger F; Dökert B
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:165-8. PubMed ID: 4728085
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study of the in vitro effect of hydrocortisone and D-penicillamine on the liver of patients with chronic hepatitis and liver cirrhosis].
    Gichev IuP; Bakulina LF
    Ter Arkh; 1980; 52(7):113-7. PubMed ID: 7404399
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative evaluation of biochemical tests to determine the activity of the pathological process in patients with chronic hepatitis and cirrhosis of the liver who are receiving glucocorticoid therapy].
    Shul'man VSh; Tatarinova OM; Barenblat GZ
    Ter Arkh; 1969 Nov; 41(11):88-93. PubMed ID: 5384756
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical and biological effectiveness of citiolone and importance of its contribution in hepatic therapeutics].
    Duché G
    Therapeutique; 1970 Dec; 46(10):1037-41. PubMed ID: 5511931
    [No Abstract]   [Full Text] [Related]  

  • 35. The incidence of oxyphenisatin-induced liver damage in chronic non-alcoholic liver disease. A controlled investigation.
    Dietrichson O; Juhl E; Nielsen JO; Oxlund JJ; Christoffersen P
    Scand J Gastroenterol; 1974; 9(5):473-8. PubMed ID: 4605276
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of chronic liver diseases with thioctic acid].
    Möller E; Brinkmann W; Weber O; Wildhirt E
    Med Klin; 1967 Mar; 62(10):380-4. PubMed ID: 4874626
    [No Abstract]   [Full Text] [Related]  

  • 37. [A contribution to the treatment of chronic liver diseases (author's transl)].
    Möller E; Schmitt R
    Med Klin; 1976 Oct; 71(43):1831-5. PubMed ID: 825708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiences with 6-mercaptopurine therapy in active chronic hepatopathies].
    Schimmelpfennig W; Schneider G; Theuer D; Wagner K; Zimmermann HB
    Dtsch Z Verdau Stoffwechselkr; 1969; 22():89-95. PubMed ID: 5380092
    [No Abstract]   [Full Text] [Related]  

  • 40. [For which liver diseases is immunosuppressive therapy indicated?].
    Bannaski H
    Med Klin Prax; 1982 Aug; 77(16-17):66-71, 74. PubMed ID: 7132889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.